Pulmatrix, Inc (PULM)

Etorro trading 970x250

About Pulmatrix, Inc

Pulmatrix, Inc., a clinical stage biopharmaceutical company, develops inhaled therapies to address serious pulmonary diseases using its inhaled Small Particles Easily Respirable and Emitted (iSPERSE) technology. Its proprietary product pipeline focuses on advancing treatments for serious lung diseases, including Pulmazole, an inhaled anti-fungal for patients with allergic bronchopulmonary aspergillosis; and PUR1800, a narrow spectrum kinase inhibitor for patients with obstructive lung diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The company has a license agreement with RespiVert Ltd. to develop kinase inhibitor for access to a portfolio of novel drug candidates; and Cipla Technologies LLC for the development and commercialization of Pulmazole. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts. Address: 99 Hayden Avenue, Lexington, MA, United States, 02421

Pulmatrix, Inc News and around…

Latest news about Pulmatrix, Inc (PULM) common stock and company :

Pulmatrix Announces First Quarter 2022 Financial Results and Provides Corporate Update
12 May, 2022 Yahoo! Finance

Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced first quarter financial results for 2022 and provided a corporate update.

Pulmatrix Announces Year-End and Q4 Financial 2021 Results and Provides Corporate Update
29 Mar, 2022 Yahoo! Finance

Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced fourth quarter and year-end financial results for 2021 and provided a corporate update.

Pulmatrix's COPD Candidate Shows Early Safety, Preliminary Pharmacokinetic Results
21 Mar, 2022 FinancialContent

Pulmatrix Inc(NASDAQ: PULM)announced topline resultsof its recently completed Phase 1b clinical study of PUR1800 in ...

Pulmatrix Announces Positive Top-Line Data Evaluating PUR1800 in Patients with Stable COPD
21 Mar, 2022 Yahoo! Finance

Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced positive top-line results of its recently completed Phase 1b clinical study of PUR1800, a narrow-spectrum kinase inhibitor (NSKI) administered as a dry powder for inhalation with iSPERSE™ for evaluation in patients with stable Chronic Obstructive Pulmonary Disease (COPD). P

Pulmatrix Regains Compliance With Nasdaq Listing Requirements
17 Mar, 2022 Yahoo! Finance

Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced that it received written notice from the Nasdaq Listing Qualifications Staff of the NASDAQ Stock Market LLC ("Nasdaq") stating that the Company regained compliance with the applicable Nasdaq minimum bid price continued listing requirement and the matter is now closed.

Which U.S. Companies Are Cutting Ties With Russia? See Latest List.
01 Mar, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips U.S. companies are cutting ties with Russia due to the war with Ukraine and we're going over which ones traders need to know about. The post Which U.S. Companies Are Cutting Ties With Russia? See Latest List. appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

PULM Stock Alert: Is Pulmatrix Really Soaring More Than 1,800% Today?
01 Mar, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips As Pulmatrix executes a reverse stock split, shares of the tiny pharmaceutical company appear to be defying gravity. The post PULM Stock Alert: Is Pulmatrix Really Soaring More Than 1,800% Today? appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Pulmatrix Announces Expansion of Executive Leadership Team to Progress Clinical Pipeline
01 Mar, 2022 Yahoo! Finance

Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, announced the hiring of Dr. Margaret Wasilewski as the Company's Chief Medical Officer effective March 1st, 2022.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
01 Mar, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It's time to get into the thick of it with a dive into the biggest pre-market stock movers for Tuesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

93 Biggest Movers From Friday
28 Feb, 2022 FinancialContent

Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI) ...

45 Stocks Moving In Friday's Mid-Day Session
25 Feb, 2022 FinancialContent

Gainers KAR Auction Services, Inc. (NYSE: KAR) shares climbed 39.2% to $19.05 after the company agreed to sell its ADESA U.S. ...

Stocks That Hit 52-Week Lows On Friday
25 Feb, 2022 FinancialContent

During Friday's trading, 54 companies set new 52-week lows. Things to Consider About Today's 52-Week ...

The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision
25 Feb, 2022 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Lilly's Co-developed ...

32 Stocks Moving in Friday's Pre-Market Session
25 Feb, 2022 FinancialContent

Gainers Cyren Ltd. (NASDAQ: CYRN) rose 54.6% to $7.48 in pre-market trading after gaining around 119% on Thursday. The company ...

12 Health Care Stocks Moving In Thursday's After-Market Session
24 Feb, 2022 FinancialContent

Gainers Unicycive Therapeutics (NASDAQ:UNCY) shares rose 27.9% to $1.65 during Thursday's after-market session. The company's market ...

Pulmatrix, Inc. Announces 1-for-20 Reverse Stock Split
24 Feb, 2022 Yahoo! Finance

Pulmatrix, Inc. ("Pulmatrix" or the "Company") (NASDAQ: PULM) a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced a 1-for-20 reverse split of its common stock, to be effective as of 4:05 p.m. Eastern Time on February 28, 2022. The Company's common stock is expected to trade on the Nasdaq Capital Market on a split-adjusted-basis when the market opens on Mar

When Will Pulmatrix, Inc. (NASDAQ:PULM) Turn A Profit?
02 Feb, 2022 Yahoo! Finance

With the business potentially at an important milestone, we thought we'd take a closer look at Pulmatrix, Inc.'s...

Pulmatrix Issues Letter to Stockholders
01 Feb, 2022 Yahoo! Finance

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, issued the following letter to stockholders from Chief Executive Officer Ted Raad.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
25 Jan, 2022 FinancialContent

Gainers Sierra Oncology (NASDAQ:SRRA) stock rose 45.6% to $22.58 during Tuesday's pre-market session. The market ...

20 Stocks Moving in Tuesday's Pre-Market Session
25 Jan, 2022 FinancialContent

Gainers Aptorum Group Limited (NASDAQ: APM) shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. ...

18 Stocks Moving in Friday's Pre-Market Session
31 Dec, 2021 FinancialContent

Gainers Medalist Diversified REIT, Inc. (NASDAQ: MDRR) rose 34.3% to $1.37 in pre-market trading after the company reported a ...

Pulmatrix Announces Closing of $6.75 Million Registered Direct Offering
17 Dec, 2021 Yahoo! Finance

Pulmatrix, Inc. (Nasdaq: PULM) ("Pulmatrix" or the "Company"), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced that it has closed its previously announced registered direct offering with certain institutional investors for the issuance and sale of an aggregate of 6,745.008 shares of convertible preferred stock and warrants to purchase up to an aggregat

12 Health Care Stocks Moving In Wednesday's Intraday Session
15 Dec, 2021 FinancialContent

Gainers Biofrontera (NASDAQ:BFRI) stock moved upwards by 28.18% to $7.05 during Wednesday's regular session. The ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
15 Dec, 2021 FinancialContent

Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market ...

Pulmatrix Announces $6.75 Million Registered Direct Offering
15 Dec, 2021 Yahoo! Finance

Pulmatrix, Inc. (Nasdaq: PULM) ("Pulmatrix" or the "Company"), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced that it has entered into a definitive agreement with certain institutional investors for the issuance and sale of an aggregate of 6,745 shares of convertible preferred stock and warrants to purchase up to an aggregate of 5,620,834 shares of co

12 Health Care Stocks Moving In Tuesday's After-Market Session
14 Dec, 2021 FinancialContent

Gainers Star Equity Hldgs (NASDAQ:STRR) shares increased by 12.15% to $2.86 during Tuesday's after-market session. Trading volume for ...

These 40 Mass. companies made the new Deloitte Fast 500 list
17 Nov, 2021 Yahoo! Finance

The list, released Wednesday, ranks the fastest-growing technology, media, telecommunications and life sciences companies based in North America.

12 Health Care Stocks Moving In Monday's Pre-Market Session
15 Nov, 2021 FinancialContent

Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 44.96% to $20.31 during Monday's pre-market ...

Pulmatrix Reports Third Quarter 2021 Financial Results and Provides Business Update
10 Nov, 2021 Yahoo! Finance

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today reports its third quarter 2021 financial results and provides a business update.

Pulmatrix Announces Resolution of Contract Dispute with Cipla
09 Nov, 2021 Yahoo! Finance

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced that it has completed an amendment to Pulmatrix's agreement with Cipla Technologies, LLC ("Cipla") for the development and commercialization of Pulmazole. The completion of the amendment resolves Pulmatrix's previously disclosed dispute with Cipla regarding the continued fu

Pulmatrix, Inc (PULM) is a NASDAQ Common Stock listed in , ,

970x250